Back to search

Article

CDK19 is a Regulator of Triple-Negative Breast Cancer Growth

2018-05-10

Abstract excerpt

Triple-negative breast cancer (TNBC) is a poor prognosis disease with no clinically approved targeted therapies. Here, using in vitro and in vivo RNA interference (RNAi) screens in TNBC patient-derived xenografts (PDX), we identify cyclin dependent kinase 19 (CDK19) as a potential therapeutic target. Using in vitro and in vivo TNBC PDX models, we validated the inhibitory effect of CDK19 knockdown on tumor ini...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5def8b59-8f5a-53f2-9492-5c5cc7d49844
DOI
10.1101/317776
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDK19 is a Regulator of Triple-Negative Breast Cancer GrowthDOI 10.1101/317776
Select a neighboring publication to make it the new centre.